| Literature DB >> 25773310 |
Peter J Siska1, Jeffrey C Rathmell2.
Abstract
T cell metabolism has a central role in supporting and shaping immune responses and may have a key role in antitumor immunity. T cell metabolism is normally held under tight regulation in an immune response of glycolysis to promote effector T cell expansion and function. However, tumors may deplete nutrients, generate toxic products, or stimulate conserved negative feedback mechanisms, such as through Programmed Cell Death 1 (PD-1), to impair effector T cell nutrient uptake and metabolic fitness. In addition, regulatory T cells are favored in low glucose conditions and may inhibit antitumor immune responses. Here, we review how the tumor microenvironment modifies metabolic and functional pathways in T cells and how these changes may uncover new targets and challenges for cancer immunotherapy and treatment.Entities:
Keywords: CTLA4; IDO; PD-1; T cell metabolism; antitumor immunity; checkpoint blockade; glycolysis; tumor microenvironment
Mesh:
Substances:
Year: 2015 PMID: 25773310 PMCID: PMC4393792 DOI: 10.1016/j.it.2015.02.007
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687